PAM
GILD icon

Peak Asset Management’s Gilead Sciences GILD Stock Holding History

Peak Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100
Closed -$7K – 131
2017
Q4 		$7K Hold
100
– – ﹤0.01% 132
2017
Q3 		$8K Sell
100
-100
-50% -$7.65K ﹤0.01% 143
2017
Q2 		$14K Buy
+200
New +$13.3K 0.01% 143

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Peak Asset Management's GILD Position: Q1 2022 in Review

Peak Asset Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 7,441 shares — an estimated $540K sold.

Peak Asset Management first reported a position in GILD in Q4 2014 and held it in 29 quarters. The position peaked at $6.66M in Q3 2018. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Peak Asset Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Peak Asset Management sold 7,441 Gilead Sciences shares in Q1 2022, an estimated $540K.
  • Peak Asset Management first reported a position in Gilead Sciences in Q4 2014 and held it in 29 quarters.
  • Peak Asset Management's Gilead Sciences position peaked at $6.66M in Q3 2018.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Peak Asset Management's 13F filing for Q1 2022, filed 12 May 2022.